Tenet Healthcare director James L. Bierman exercised 1,333 restricted stock units into common stock. On this transaction date, 1,333 units, each economically equivalent to one share of Tenet Healthcare common stock, converted into 1,333 shares at a stated price of $0.00 per share.
Following the exercise, Bierman directly holds 36,604 shares of Tenet Healthcare common stock. The derivative award labeled as 2025 May Restricted Stock Units now shows zero remaining units, indicating this specific RSU grant has been fully settled into shares.
Tenet Healthcare director Christopher S. Lynch reported a routine equity compensation event. On May 22, 2026, he exercised 1,333 2025 May Restricted Stock Units, each equivalent to one share of Tenet Healthcare common stock, receiving 1,333 shares of Common Stock at a stated price of $0.00 per share.
Following the transaction, Lynch directly held 13,405 shares of Tenet Healthcare common stock. The derivative position in the 2025 May Restricted Stock Units was reduced to zero. A footnote states that his total reported holdings reflect a decrease of 278 shares from previously filed Forms 4 to correct an error.
Tenet Healthcare Corp director Nadja West reported routine equity compensation activity. On May 22, 2026, West exercised 1,333 restricted stock units that were economically equivalent to common shares, receiving Tenet common stock at a conversion price of $0.00 per share.
In connection with this settlement, 37% of the restricted stock units were settled for cash and 63% were settled in shares of Tenet common stock. West also disposed of 493 common shares back to the issuer at $173.78 per share. After these transactions, West directly owned 27,805 shares of Tenet common stock.
Tammy Romo, a director of Tenet Healthcare, exercised 1,333 2025 May restricted stock units into 1,333 shares of common stock on May 22, 2026. A footnote explains that each unit was the economic equivalent of one share and that 37% of the units were settled for cash and 63% for shares.
On the same date, Romo disposed of 493 shares of common stock to the issuer at $173.78 per share. After these transactions, Romo directly holds 35,706 shares of Tenet Healthcare common stock.
Tenet Healthcare director Richard W. Fisher reported routine equity compensation activity. On May 22, 2026, he exercised 1,333 restricted stock units into common stock, then disposed of 493 shares back to the issuer at $173.78 per share. A footnote states that 37% of his restricted stock units were settled for cash and 63% for Tenet common shares. Following these transactions, he directly holds 9,632 shares of Tenet Healthcare common stock.
Tenet Healthcare Corp director Meghan Fitzgerald reported routine equity compensation activity involving company common stock. On May 22, 2026, she exercised 1,333 restricted stock units, receiving the same number of Tenet common shares. The filing notes each unit was economically equivalent to one THC share.
On the same date, she disposed of 493 common shares back to the issuer at $173.78 per share. After these transactions, she held 17,087 shares of Tenet Healthcare common stock directly, and the referenced 2025 May restricted stock units were fully settled.
Director Vineeta Agarwala of Tenet Healthcare Corp exercised previously granted equity awards and increased her direct holdings of common stock. She converted 1,333 restricted stock units, each equivalent to one share of Tenet common stock, into the same number of common shares. Following this transaction, she directly owns 4,446 shares of Tenet common stock. The filing shows an exercise of derivative securities with no reported open-market purchases or sales.
Tenet Healthcare Corp director Cecil D. Haney reported routine equity compensation activity involving restricted stock units and common shares. He exercised derivative securities labeled as 2025 May Restricted Stock Units into 1,333 shares of common stock, with the units economically equivalent to Tenet common stock. A portion of this award was settled in cash and the remainder in shares, as described in the footnote. The filing also shows a disposition of 493 common shares back to the issuer at $173.78 per share. After these transactions, Haney directly holds 13,853 shares of Tenet common stock.
Tenet Healthcare Corp director Richard J. Mark reported compensation-related share movements. On 2026-05-22, he exercised 1,333 restricted stock units into an equal number of common shares at an exercise price of $0.00 per share.
On the same date, he disposed of 493 common shares back to the issuer in a transaction coded "D" at $173.78/share. After these transactions, he directly held 35,121 shares of Tenet Healthcare common stock. A footnote explains that he settled 37% of his restricted stock units for cash and 63% for shares.
Tenet Healthcare director J. Robert Kerrey reported routine equity compensation activity involving company stock. He exercised 1,643 restricted stock units, which were each the economic equivalent of one share of Tenet common stock, receiving value partly in cash and partly in shares.
According to the footnote, Kerrey settled 37% of these units for cash and 63% for shares. On the same date, he also disposed of 607 common shares to the issuer in a transaction coded as a disposition to issuer. After these transactions, he directly held 22,442 shares of Tenet common stock, indicating that the activity represents a relatively small adjustment to his overall ownership position.